Form 4: Option Care Health Director Receives Equity Grant

Director Barbara W. Bodem was granted 8,997 restricted stock units valued at $200,000 as part of annual compensation.

Summary

• Director Barbara W. Bodem received an award of 8,997 restricted stock units (RSUs) on May 20, 2026.
• The grant represents $200,000 in value based on the closing price of Option Care Health common stock on the date of the grant.
• The RSUs are scheduled to vest in full on May 20, 2027.
• Following this transaction, the director's total beneficial ownership of common stock increased to 21,087 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation that carries no material impact on company operations.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Standardized compensation structure for board members.

Negatives

• None identified; this is a routine disclosure of director compensation.

Risks

• None identified; this is a standard equity grant disclosure.

Future Outlook

The filing does not provide forward-looking financial guidance, as it is a routine disclosure of director equity compensation.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are a standard corporate governance practice in the healthcare services sector to ensure board alignment with long-term shareholder value.

Comparison to Industry Standards

• The grant of $200,000 in equity is consistent with typical annual compensation packages for directors at mid-cap healthcare companies.
• The one-year cliff vesting schedule is a common practice for director equity awards.

Stakeholder Impact

• Minimal impact on shareholders as the grant is part of standard director compensation.

Next Steps

• Vesting of the restricted stock units on May 20, 2027.

Key Dates

Keywords

Option Care Health, OPCH, Form 4, Insider Trading, Director Compensation, Restricted Stock Units